Exabis Library
Welcome to the e-CCO Library!
P676: Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P676: Correlation of lipid levels with reduction in inflammation in patients with ulcerative colitis: Data from the tofacitinib OCTAVE clinical trials
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P676: Intestinal ultrasound accurately predicts therapy failure in Crohn's disease patients during a biologics-induced remission
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P676: The impact to disease activity, iron and vitamin D deficiency on fatigue in IBD patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P676: The small intestinal microbiome in Crohn’s disease is characterised by increased luminal diversity and stable mucosa-associated communities
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P677 It’s time to grow up: what is it like to transition from the paediatric to adult inflammatory bowel disease service?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P677: Azathioprine dosing and metabolite measurement in paediatric inflammatory bowel disease—does one size fit all?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P677: Combination of vedolizumab and exclusive enteral nutrition in patients with moderate to severe Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P677: Effect of late faecal loss of infliximab on treatment response of inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P677: Fungal abundance is related to inflammatory status in Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P677: Impact of patient reported outcomes, coping strategies and psychosocial factors on medication adherence in inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P677: Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registry
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P678 Effect of accelerated infliximab induction on short-term outcomes of paediatric acute severe ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P678: Definition of a microbial signature as a predictor of post-surgical recurrence in patients with Crohn's disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P678: Did toxicity profile of azathioprine changed within the last 10 years: comparative 17 years data from a single tertiary IBD center
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P678: Rare and severe complications in paediatric Inflammatory Bowel Disease: results of 5 years of international collaboration through the PIBD-SETQuality Safety Registry
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P678: Risk of malnutrition in patients with inflammatory bowel diseases: Results from an Italian multi-centre observational cross-sectional study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P678: Treatment of moderate to severe UC patients with new 5ASA tablets
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P678: Ustekinumab therapy improves the nutritional status in patients with Crohn's Disease. A prospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P679 What is the best strategy after failure to anti-TNF? Ustekinumab or other anti-TNF?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM